Viewing Study NCT06229067


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2025-12-25 @ 10:48 PM
Study NCT ID: NCT06229067
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-29
First Post: 2024-01-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module